MoonLake Immunotherapeutics Receives Regulatory Greenlights for Phase 3 Program of Sonelokimab in PsA

June 10, 2024

AARS Offers Social Toolkit to Help Spread #AcneFacts During National Acne Awareness Month

May 28, 2024

News You Can Use: First Global HS Atlas Now Available From GHiSA, ILDS

May 28, 2024

Phase 3 Data: Bimekizumab Earns High Marks in HS

May 23, 2024

HS Pipeline Watch: MoonLake Immunotherapeutics’ Sonelokimab Advances to Phase 3

May 16, 2024

Adalimumab Improves Hematologic Abnormalities in HS Patients

May 9, 2024

Study: Stigma Affects Quality of Life for Kids With Chronic Skin Diseases

April 24, 2024

FDA Accepts UCB’s sBLA for 2 mL Bimzelx Device

April 22, 2024

FDA Accepts UCB’s sBLA for Bimzelx in HS

April 22, 2024

EC Green Lights Bimzelx for HS

April 22, 2024

UCB Launches ‘Make HStory’ Campaign for People Living with HS and Their Doctors

April 11, 2024

MoonLake, Komodo Health Partner to Study Inflammatory Skin and Joint Conditions

April 10, 2024